Mechanisms of ketamine-induced immunosuppression

研究成果: 雜誌貢獻文章同行評審

23 引文 斯高帕斯(Scopus)


Ketamine, a noncompetitive N-methyl-d-Aspartate receptor antagonist, is widely used as an intravenous anesthetic agent. It is known to produce increases in blood pressure and stroke volume, which implies its importance in clinical practice. Ketamine has also been shown to possess anti-inflammatory effects. Our previous studies showed that ketamine, at clinically relevant concentrations, can downregulate endotoxin-induced macrophage activation through toll-like receptor-dependent activation of mitogen-Activated protein kinases and the transcription factors nuclear factor-kappa B and activator protein-1. As to the responsible mechanisms, considerable attention was devoted to ketamine-involved regulation of proinflammatory gene expression. The assessment of how ketamine regulates proinflammatory gene expressions is significant in determining the signal cascades that are influenced by this anesthetic agent and its clinical application in the tactical use of ketamine in preventing sepsis. Herein, we review the literature on the pharmacodynamics, pharmacokinetics, and possible mechanisms involved in ketamine's immunology.

頁(從 - 到)172-177
期刊Acta Anaesthesiologica Taiwanica
出版狀態已發佈 - 十二月 2012

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

指紋 深入研究「Mechanisms of ketamine-induced immunosuppression」主題。共同形成了獨特的指紋。